• Home
  • Stock
  • Aarti Drugs Fundamental Analysis
  • Aarti Drugs Fundamental Analysis

Aarti Drugs fundamental analysis

AARTIDRUGS

HealthcareMid

469.1

5.90 (-1.24%)
Last updated on 13 Nov, 2025 | 15:59 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Aarti Drugs Fundamentals

P/E Ratio

21.72

P/B Ratio

2.95

Div. Yield

0.21

Sector P/E

38.25

Sector P/B

3.67

Sec. Div. Yield

0.56

  • Aarti Drugs Fundamentals is currently trading with a P/E Ratio of 21.72, compared to the sector average of 38.25. Its P/B Ratio stands at 2.95, while the sector’s is 3.67. In terms of returns, the stock offers a Dividend Yield of 0.21%, which is than the sector’s 0.56%.

Aarti Drugs Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Aarti Drugs reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.